Vaccines

01 Oct 2009 Updated Advaxis Phase I Survival Data Indicates Long-Term Immune Protection
29 Sep 2009 Dynavax Initiates Phase 3 Registration Trial in Chronic Kidney Disease Patients for HEPLISAVTM Hepatitis B Vaccine
25 Sep 2009 Novartis A(H1N1) Pandemic Influenza vaccine Focetria® receives positive opinion from CHMP
25 Sep 2009 Pandemic (H1N1) 2009 Influenza Update: GSK’s H1N1 ‘Pandemrix’ vaccine receives positive opinion from European Regulators
25 Sep 2009 Wyeth Receives Positive Opinion from European Regulators for its 13-valent Pneumococcal Candidate Vaccine for Infants and Young Children
24 Sep 2009 Vical Presents Positive Preclinical Results with Vaxfectin(R)-Formulated, Peptide-based Cancer Vaccine
24 Sep 2009 Sanofi Pasteur Commends Results of First HIV Vaccine Study to Show Some Effectiveness in Preventing HIV
22 Sep 2009 New and interesting PROSTVAC™ data indicate broad therapeutic use in metastatic prostate cancer
22 Sep 2009 Oxford BioMedica Presents Interim Results From Phase III TRIST Study of TroVax® In Renal Cancer
22 Sep 2009 Simcere Pharmaceutical Group Invested Company Obtains Production License for H1N1 Flu Vaccine
16 Sep 2009 STALLERGENES: Immunotherapy Tablet Containing Recombinant Allergen (rBet v 1) of Birch Pollen: Positive Results for a Phase IIb/III Trial
16 Sep 2009 FDA Approves Vaccines for 2009 H1N1 Influenza Virus
14 Sep 2009 Pandemic (H1N1) 2009 Influenza Update: Initial results from first clinical trial of GSK’s H1N1 adjuvanted vaccine
14 Sep 2009 Variation Biotechnologies Flu Vaccine Provides Robust Immune Response, Broad Protection against H1N1 Influenza Strain
14 Sep 2009 Celldex Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Trial of its CDX-1401 Cancer Vaccine Candidate
11 Sep 2009 CSL DEMONSTRATES ROBUST IMMUNE RESPONSE FROM SINGLE (15mcg) DOSE OF MONOVALENT PANDEMIC (H1N1) 2009 INFLUENZA A VACCINE IN HEALTHY ADULTS
10 Sep 2009 Dynavax Reports FDA Removes Clinical Hold on HEPLISAVTM Phase 3 Hepatitis B Vaccine
10 Sep 2009 FDA Advisory Committee makes favorable recommendation for Cervarix, GlaxoSmithKline’s candidate cervical cancer vaccine
10 Sep 2009 Vical Pandemic Influenza Vaccine Demonstrates Cross-reactivity Against California, Texas and Mexico H1N1 Strains
08 Sep 2009 NanoBio’s Vaccine Adjuvant Platform Demonstrates Robust Immunity and Cross Protection Against Influenza
08 Sep 2009 Opexa Reports Additional Favorable Data with Tovaxin® for Multiple Sclerosis
03 Sep 2009 PharmAthene Presents Data for Valortim(R) Anthrax Anti-Toxin and Third Generation rPA Anthrax Vaccine Programs at the Bacillus - ACT 2009 Conference
03 Sep 2009 Novartis MF59® adjuvanted cell culture-based vaccine shows strong immune response in A(H1N1) clinical trials
03 Sep 2009 Sinovac Obtains Production License for H1N1 Vaccine
31 Aug 2009 Sinovac's H1N1 Vaccine Passes Experts Evaluation Organized by SFDA

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top